The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, today announced that Phil Skolnick, Ph.D., D.Sc. (hon.), a leader in the worlds of corporate and academic drug research, has been appointed Director of NIDA’s Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA).